Search Results

There are 9081 results for: content related to: Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

  1. You have free access to this content
    Poster Session 1: Cellular Immunobiology, Preservation, and Cell Transplantation in Transplant; Clinical: Hepatocellular Carcinoma and Cholangiocarcinoma

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 380A–456A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28212

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1458–1467, Yee Chao, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim and Teng-Yu Lee

    Version of Record online : 16 SEP 2014, DOI: 10.1002/ijc.29126

  4. Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

    Hepatology Research

    Volume 42, Issue 6, June 2012, Pages: 523–542, Shuichi Kaneko, Junji Furuse, Masatoshi Kudo, Kenji Ikeda, Masao Honda, Yasunari Nakamoto, Morikazu Onchi, Goshi Shiota, Osamu Yokosuka, Isao Sakaida, Tetsuo Takehara, Yoshiyuki Ueno, Kazumasa Hiroishi, Shuhei Nishiguchi, Hisataka Moriwaki, Kazuhide Yamamoto, Michio Sata, Shuntaro Obi, Shiro Miyayama and Yukinori Imai

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1872-034X.2012.00981.x

  5. Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma

    Hepatology Research

    Volume 44, Issue 3, March 2014, Pages: 302–312, Haruhiko Takeda, Hiroki Nishikawa, Eriko Iguchi, Yoshiaki Ohara, Azusa Sakamoto, Sumio Saito, Norihiro Nishijima, Akihiro Nasu, Hideyuki Komekado, Ryuichi Kita, Toru Kimura and Yukio Osaki

    Version of Record online : 29 APR 2013, DOI: 10.1111/hepr.12125

  6. Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 12, December 2013, Pages: 1834–1841, Daisuke Miyaki, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Ayako Urabe, Keiichi Masaki, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Shoichi Takahashi, Masaki Ishikawa, Hideaki Kakizawa, Kazuo Awai and Kazuaki Chayama

    Version of Record online : 22 NOV 2013, DOI: 10.1111/jgh.12311

  7. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2147–2154, Yu Yang, Feng Wen, Jianliang Li, Pengfei Zhang, Wenhui Yan, Ping Hao, Feng Xia, Feng Bi and Qiu Li

    Version of Record online : 7 MAR 2015, DOI: 10.1111/liv.12805

  8. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  9. Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting

    Journal of Digestive Diseases

    Volume 16, Issue 3, March 2015, Pages: 143–151, Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda and Katsuaki Tanaka

    Version of Record online : 27 MAR 2015, DOI: 10.1111/1751-2980.12221

  10. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

    Liver International

    Volume 34, Issue 5, May 2014, Pages: 795–801, Ju-Yeon Cho, Yong-Han Paik, Hee Chul Park, Jeong Il Yu, Won Sohn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik and Byung Chul Yoo

    Version of Record online : 12 JAN 2014, DOI: 10.1111/liv.12445

  11. You have free access to this content
    New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E1–E11, Makoto Chuma, Katsumi Terashita and Naoya Sakamoto

    Version of Record online : 9 JAN 2015, DOI: 10.1111/hepr.12459

  12. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma

    Journal of Digestive Diseases

    Volume 16, Issue 9, September 2015, Pages: 505–512, Tomokazu Kawaoka, Hiroshi Aikata, Hideyuki Hyogo, Reona Morio, Kei Morio, Masahiro Hatooka, Takayuki Fukuhara, Tomoki Kobayashi, Noriaki Naeshiro, Daisuke Miyaki, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi, Koji Waki, Keiji Tsuji, Hirotaka Kohno, Hiroshi Kohno, Takashi Moriya and Kazuaki Chayama

    Version of Record online : 28 SEP 2015, DOI: 10.1111/1751-2980.12267

  13. Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 620–626, Jens Ricke, Karsten Bulla, Frank Kolligs, Markus Peck-Radosavljevic, Peter Reimer, Bruno Sangro, Eckart Schott, Kerstin Schütte, Chris Verslype, Jerzy Walecki, Peter Malfertheiner and for the SORAMIC study group

    Version of Record online : 8 JUL 2014, DOI: 10.1111/liv.12622

  14. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 156–163, Feng DUAN, Mao Qiang WANG, Feng Yong LIU, Zhi Jun WANG, Peng SONG and Yan WANG

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01542.x

  15. You have free access to this content
    Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E130–E140, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 3 MAR 2015, DOI: 10.1111/hepr.12480

  16. You have free access to this content
    Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 165–173, Alessandro Vitale, Michael L. Volk, Davide Pastorelli, Sara Lonardi, Fabio Farinati, Patrizia Burra, Paolo Angeli and Umberto Cillo

    Version of Record online : 31 AUG 2009, DOI: 10.1002/hep.23260

  17. You have free access to this content
    Nuclear factor kappa B–mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 534–545, Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng and Terence Kin Wah Lee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/hep.27859

  18. You have free access to this content
    Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

    HPB

    Volume 17, Issue 1, January 2015, Pages: 52–65, Gino Boily, Jean-Pierre Villeneuve, Luc Lacoursière, Prosanto Chaudhury, Félix Couture, Jean-François Ouellet, Réal Lapointe, Stéphanie Goulet, Normand Gervais and the Comité de l'évolution des pratiques en oncologie

    Version of Record online : 24 JUN 2014, DOI: 10.1111/hpb.12273

  19. Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1032–1039, Li Xu, Hengjun Gao, Junting Huang, Haoyuan Wang, Zhongguo Zhou, Yaojun Zhang, Shaohua Li and Minshan Chen

    Version of Record online : 27 APR 2015, DOI: 10.1111/jgh.12910

  20. You have free access to this content
    Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

    Hepatology

    Volume 54, Issue 6, December 2011, Pages: 2055–2063, Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, Claudio Zavaglia, Antonio Grieco, Erica Villa, Calogero Cammà, Massimo Colombo and on behalf of the SOFIA (SOraFenib Italian Assessment) study group

    Version of Record online : 30 NOV 2011, DOI: 10.1002/hep.24644